Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

09:30
10/13/16
10/13
09:30
10/13/16
09:30

Bristol-Myers downgraded to Buy from Conviction Buy at Goldman

Goldman analyst Jami Rubin removed Bristol-Myers from the Conviction Buy List and lowered its price target to $67 from $75 saying disappointing CM-26 data adds a greater level of uncertainty to future trials. He continues to believe is well positioned for 2017, and view the shares as very attractive over the long-term.

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers

09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.

TODAY'S FREE FLY STORIES

DISCA

Discovery

$29.62

0.94 (3.28%)

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Downgrade
Discovery rating change  »

Discovery downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISIL

Intersil

$22.20

0.02 (0.09%)

, RNECY

Renesas

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Hot Stocks
Intersil, Renesas announce regulatory approval for acquisition of Intersil »

Renesas Electronics…

ISIL

Intersil

$22.20

0.02 (0.09%)

RNECY

Renesas

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTL

Entellus Medical

$17.08

0.06 (0.35%)

05:36
02/22/17
02/22
05:36
02/22/17
05:36
Downgrade
Entellus Medical rating change  »

Entellus Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$16.05

-2.95 (-15.53%)

05:34
02/22/17
02/22
05:34
02/22/17
05:34
Downgrade
Momenta rating change  »

Leerink downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$78.44

0.66 (0.85%)

05:33
02/22/17
02/22
05:33
02/22/17
05:33
Hot Stocks
Bunge forms JV with Bahri, terms not disclosed »

Bahri Dry Bulk, or BDB, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AU

AngloGold

$12.54

-0.36 (-2.79%)

05:30
02/22/17
02/22
05:30
02/22/17
05:30
Downgrade
AngloGold rating change  »

AngloGold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Hot Stocks
Toll Brothers backs FY17 adjusted gross margin »

Toll Brothers reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

STM

STMicroelectronics

$14.64

0.38 (2.66%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Upgrade
STMicroelectronics rating change  »

STMicroelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZSEY

Allianz

$17.45

0.13 (0.75%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Initiation
Allianz initiated  »

Allianz initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$48.62

0.42 (0.87%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Downgrade
InterContinental rating change  »

InterContinental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUKOY

Lukoil

$55.80

0.87 (1.58%)

05:24
02/22/17
02/22
05:24
02/22/17
05:24
Upgrade
Lukoil rating change  »

Lukoil upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:23
02/22/17
02/22
05:23
02/22/17
05:23
Earnings
Toll Brothers reports Q1 EPS 42c, consensus 35c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

QCOM

Qualcomm

$56.75

0.29 (0.51%)

, CHL

China Mobile

$56.46

0.35 (0.62%)

05:17
02/22/17
02/22
05:17
02/22/17
05:17
Hot Stocks
Qualcomm, China Mobile, ZTE announce collaboration on 5G NR trials »

Qualcomm Technologies, a…

QCOM

Qualcomm

$56.75

0.29 (0.51%)

CHL

China Mobile

$56.46

0.35 (0.62%)

ZTCOY

ZTE Corp.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ECL

Ecolab

$124.03

0.08 (0.06%)

04:58
02/22/17
02/22
04:58
02/22/17
04:58
Downgrade
Ecolab rating change  »

Ecolab downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$61.02

1.79 (3.02%)

, TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$61.02

1.79 (3.02%)

TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

TWNK

Hostess Brands

$15.47

-0.13 (-0.83%)

MJN

Mead Johnson

$87.47

-0.03 (-0.03%)

K

Kellogg

$74.74

1.84 (2.52%)

MDLZ

Mondelez

$44.97

2.47 (5.81%)

INGR

Ingredion

$122.02

1.23 (1.02%)

LNCE

Snyder's-Lance

$39.38

0.38 (0.97%)

SYY

Sysco

$52.81

0.46 (0.88%)

JNJ

Johnson & Johnson

$119.66

0.8 (0.67%)

SJM

J.M. Smucker

$141.92

5.97 (4.39%)

MO

Altria Group

$73.65

0.68 (0.93%)

CPB

Campbell Soup

$58.95

0.47 (0.80%)

PEP

PepsiCo

$109.36

1.21 (1.12%)

CLX

Clorox

$135.44

1.73 (1.29%)

BG

Bunge

$78.44

0.66 (0.85%)

PG

Procter & Gamble

$91.67

0.58 (0.64%)

DANOY

Danone

$12.92

-0.125 (-0.96%)

SPB

Spectrum Brands

$134.58

0.67 (0.50%)

KO

Coca-Cola

$41.46

0.23 (0.56%)

IFF

International Flavors

$121.62

-0.75 (-0.61%)

STZ

Constellation Brands

$160.09

-1.23 (-0.76%)

NSRGY

Nestle

$72.92

-0.825 (-1.12%)

CHD

Church & Dwight

$49.61

-0.09 (-0.18%)

UN

Unilever; also tag UL

$45.09

-3.7 (-7.58%)

CL

Colgate-Palmolive

$73.18

1.2 (1.67%)

NWL

Newell Brands

$46.49

-0.15 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

RIO

Rio Tinto

$44.89

0.65 (1.47%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 24

    Feb

  • 26

    Feb

CRUS

Cirrus Logic

$55.17

-0.16 (-0.29%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Cirrus Logic management to meet with Canaccord »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VWDRY

Vestas

$24.97

0.34 (1.38%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MPWR

Monolithic Power

$88.22

1.7 (1.96%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Monolithic Power management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 04

    Apr

  • 05

    Apr

WEB

Web.com

$20.40

0.2 (0.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Web.com management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

OCLR

Oclaro

$10.97

-0.05 (-0.45%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Oclaro management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

HAS

Hasbro

$98.88

0.38 (0.39%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Hasbro management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

FLWS

1-800-Flowers.com

$10.10

0.1 (1.00%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
1-800-Flowers.com management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

04:55
02/22/17
02/22
04:55
02/22/17
04:55
General news
Breaking General news story  »

FOMC Minutes to be…

04:55
02/22/17
02/22
04:55
02/22/17
04:55
General news
Breaking General news story  »

Federal Reserve Gov.…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.